These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 32018254

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A comparison of volumetric modulated arc therapy and sliding-window intensity-modulated radiotherapy in the treatment of Stage I-II nasal natural killer/T-cell lymphoma.
    Liu X, Yang Y, Jin F, He Y, Zhong M, Luo H, Qiu D, Li C, Yang H, He G, Wang Y.
    Med Dosim; 2016; 41(1):42-6. PubMed ID: 26428072
    [Abstract] [Full Text] [Related]

  • 4. Application of 3D-print silica bolus for nasal NK/T-cell lymphoma radiation therapy.
    Dai G, Xu X, Wu X, Lei X, Wei X, Li Z, Xiao Q, Zhong R, Bai S.
    J Radiat Res; 2020 Nov 16; 61(6):920-928. PubMed ID: 32960262
    [Abstract] [Full Text] [Related]

  • 5. Volumetric-modulated arc therapy versus intensity-modulated radiotherapy for large volume retroperitoneal sarcomas: A comparative analysis of dosimetric and treatment delivery parameters.
    Taggar AS, Graham D, Kurien E, Gräfe JL.
    J Appl Clin Med Phys; 2018 Jan 16; 19(1):276-281. PubMed ID: 29178585
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Mild toxicity and favorable prognosis of high-dose and extended involved-field intensity-modulated radiotherapy for patients with early-stage nasal NK/T-cell lymphoma.
    Wang H, Li YX, Wang WH, Jin J, Dai JR, Wang SL, Liu YP, Song YW, Wang ZY, Liu QF, Fang H, Qi SN, Liu XF, Yu ZH.
    Int J Radiat Oncol Biol Phys; 2012 Mar 01; 82(3):1115-21. PubMed ID: 21514070
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparisons of skin toxicity in patients with extranodal nasal-type natural killer/T-cell lymphoma after treatment with intensity-modulated radiotherapy and conventional radiotherapy.
    Gu Y, Yu H, Zuo X, Cao Q, Liang T, Ren Y, Yang H, Yang D.
    J Cancer Res Ther; 2018 Dec 01; 14(Supplement):S975-S979. PubMed ID: 30539832
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. 18 F-Fluoromisonidazole positron emission tomography/CT-guided volumetric-modulated arc therapy-based dose escalation for hypoxic subvolume in nasopharyngeal carcinomas: A feasibility study.
    Qiu J, Lv B, Fu M, Wang X, Zheng X, Zhuo W.
    Head Neck; 2017 Dec 01; 39(12):2519-2527. PubMed ID: 28963789
    [Abstract] [Full Text] [Related]

  • 16. Sparing of normal tissues with volumetric arc radiation therapy for glioblastoma: single institution clinical experience.
    Briere TM, McAleer MF, Levy LB, Yang JN.
    Radiat Oncol; 2017 May 02; 12(1):79. PubMed ID: 28464840
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Estimation of radiotherapy modalities for patients with stage I-II nasal natural killer T-Cell lymphoma.
    Liu X, Wu F, Guo Q, Wang Y, He Y, Luo H, Li Q, Zhong M, Li C, Yang H, Zhou J, Jin F.
    Cancer Manag Res; 2019 May 02; 11():7219-7229. PubMed ID: 31534370
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Flattening Filter-Free Beams in Intensity-Modulated Radiotherapy and Volumetric Modulated Arc Therapy for Sinonasal Cancer.
    Lu JY, Zheng J, Zhang WZ, Huang BT.
    PLoS One; 2016 May 02; 11(1):e0146604. PubMed ID: 26734731
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.